Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ansel P Nalin

Showing results (1-10 of 24) with videos related to

Pageof 3
Sort By:
Tetrahedron|September 24, 2013
Concise enantioselective synthesis of diospongins A and BEric Stefan, Ansel P Nalin, Richard E Taylor
Journal of Leukocyte Biology|March 4, 2023
Deciphering the localization and trajectory of human natural killer cell developmentEverardo Hegewisch-Solloa, Ansel P Nalin, Aharon G Freud, et al.
Hospital Pediatrics|May 22, 2021
Pediatric Family-Centered Rounds and Humanism: A Systematic Review and Qualitative Meta-analysisAshley K Fernandes, Sheria Wilson, Ansel P Nalin, et al.
Cancer Discovery|July 26, 2019
The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic EffectorWenjuan Dong, Xiaojin Wu, Shoubao Ma, et al.
Cancer|February 7, 2026
Control arm overperformance in phase 3 oncology clinical trialsAnsel P Nalin, Pavlos Msaouel, Adam J Grippin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2021
Disparate Use of Chemoradiation in Elderly Patients With Localized Anal CancerEric D Miller, Ansel P Nalin, Dayssy A Diaz Pardo, et al.
American Journal of Cancer Research|July 24, 2018
First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemiaXiaowen Tang, Lin Yang, Zheng Li, et al.
Oncoimmunology|June 7, 2018
The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cellsXinxin Li, Wenjuan Dong, Ansel P Nalin, et al.
Practical Radiation Oncology|October 8, 2025
Real-World Guide for Delivering Immunotherapy With Radiation TherapyDenton J Robinson, Hampartsoum B Barsoumian, Ansel P Nalin, et al.
American Journal of Cancer Research|October 17, 2018
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemiaXiaowen Tang, Lin Yang, Zheng Li, et al.
Pageof 3

Showing results (1-10 of 24) with videos related to

Sort By:
Pageof 3
Tetrahedron|September 24, 2013
Concise enantioselective synthesis of diospongins A and BEric Stefan, Ansel P Nalin, Richard E Taylor
Journal of Leukocyte Biology|March 4, 2023
Deciphering the localization and trajectory of human natural killer cell developmentEverardo Hegewisch-Solloa, Ansel P Nalin, Aharon G Freud, et al.
Hospital Pediatrics|May 22, 2021
Pediatric Family-Centered Rounds and Humanism: A Systematic Review and Qualitative Meta-analysisAshley K Fernandes, Sheria Wilson, Ansel P Nalin, et al.
Cancer Discovery|July 26, 2019
The Mechanism of Anti-PD-L1 Antibody Efficacy against PD-L1-Negative Tumors Identifies NK Cells Expressing PD-L1 as a Cytolytic EffectorWenjuan Dong, Xiaojin Wu, Shoubao Ma, et al.
Cancer|February 7, 2026
Control arm overperformance in phase 3 oncology clinical trialsAnsel P Nalin, Pavlos Msaouel, Adam J Grippin, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|June 10, 2021
Disparate Use of Chemoradiation in Elderly Patients With Localized Anal CancerEric D Miller, Ansel P Nalin, Dayssy A Diaz Pardo, et al.
American Journal of Cancer Research|July 24, 2018
First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemiaXiaowen Tang, Lin Yang, Zheng Li, et al.
Oncoimmunology|June 7, 2018
The natural product chitosan enhances the anti-tumor activity of natural killer cells by activating dendritic cellsXinxin Li, Wenjuan Dong, Ansel P Nalin, et al.
Practical Radiation Oncology|October 8, 2025
Real-World Guide for Delivering Immunotherapy With Radiation TherapyDenton J Robinson, Hampartsoum B Barsoumian, Ansel P Nalin, et al.
American Journal of Cancer Research|October 17, 2018
Erratum: First-in-man clinical trial of CAR NK-92 cells: safety test of CD33-CAR NK-92 cells in patients with relapsed and refractory acute myeloid leukemiaXiaowen Tang, Lin Yang, Zheng Li, et al.
Pageof 3